Protocol No
COLUMBIAUNIVERSITY-AAAT8639
Phase
I/II
Summary
This project is being done to investigate whether Venetoclax is safe in patients with AL amyloidosis and identify the optimal dose.
Description
A Phase I/II Trial of Venetoclax + Dexamethasone in R/R Systemic Light-Chain Amyloidosis
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov